In summary, we show here how the use of computational tools can imply changes in pathway activities from miRNA expression profiles, leading in this case to the identification of activin/TGF-β family signaling as a potential mediator of chemo-resistance both in a cell line model and in primary AML. This evidence concerns the gene TGFB1 and acute myeloid leukemia.